| # | Company | Symbol | Weight | Price | Chg | % Chg |
|---|---|---|---|---|---|---|
| 1 | Tempus Ai Inc | TEM | 9.25% | 66.16 |
1.55 | (2.40%) |
| 2 | Crispr Therapeutics Ag | CRSP | 8.94% | 56.26 |
1.52 | (2.78%) |
| 3 | Guardant Health Inc | GH | 5.64% | 98.73 |
1.26 | (1.30%) |
| 4 | Twist Bioscience Corp | TWST | 5.58% | 33.44 |
1.31 | (4.08%) |
| 5 | Personalis Inc | PSNL | 5.09% | 8.27 |
0.53 | (6.82%) |
| 6 | Beam Therapeutics Inc | BEAM | 4.85% | 26.52 |
0.92 | (3.59%) |
| 7 | Natera Inc | NTRA | 4.56% | 227.05 |
1.55 | (0.69%) |
| 8 | Illumina Inc | ILMN | 4.43% | 133.25 |
3.69 | (2.85%) |
| 9 | 10x Genomics Inc-Class A | TXG | 4.17% | 16.49 |
0.74 | (4.67%) |
| 10 | Recursion Pharmaceuticals-A | RXRX | 3.96% | 4.84 |
0.16 | (3.50%) |
| 11 | Veracyte Inc | VCYT | 3.84% | 43.12 |
0.91 | (2.14%) |
| 12 | Absci Corp | ABSI | 3.45% | 3.53 |
0.14 | (4.10%) |
| 13 | Caredx Inc | CDNA | 3.33% | 19.87 |
0.38 | (1.97%) |
| 14 | Ionis Pharmaceuticals Inc | IONS | 3.14% | 78.03 |
0.95 | (1.23%) |
| 15 | Schrodinger Inc | SDGR | 2.92% | 17.67 |
0.27 | (1.55%) |
| 16 | Adaptive Biotechnologies | ADPT | 2.87% | 16.77 |
0.65 | (4.02%) |
| 17 | Nurix Therapeutics Inc | NRIX | 2.43% | 18.42 |
0.21 | (1.18%) |
| 18 | Intellia Therapeutics Inc | NTLA | 2.34% | 9.00 |
0.21 | (2.35%) |
| 19 | Genedx Holdings Corp | WGS | 2.12% | 139.32 |
3.38 | (2.48%) |
| 20 | Pacific Biosciences of Calif | PACB | 1.79% | 2.01 |
0.07 | (3.89%) |
| 21 | Butterfly Network Inc | BFLY | 1.68% | 3.46 |
0.29 | (9.27%) |
| 22 | Prime Medicine Inc | PRME | 1.56% | 3.87 |
0.13 | (3.48%) |
| 23 | Arcturus Therapeutics Holdin | ARCT | 1.51% | 0.00 |
0.00 | (0.00%) |
| 24 | Amgen Inc | AMGN | 1.19% | 327.49 |
1.48 | (0.45%) |
| 25 | Cerus Corp | CERS | 1.17% | 2.24 |
0.05 | (2.28%) |
| 26 | Atai Beckley Nv | ATAI | 1.13% | 4.19 |
0.13 | (3.25%) |
| 27 | Compass Pathways Plc | CMPS | 1.11% | 6.32 |
0.12 | (2.00%) |
| 28 | Incyte Corp | INCY | 1.07% | 98.11 |
0.48 | (0.49%) |
| 29 | Vertex Pharmaceuticals Inc | VRTX | 0.96% | 451.38 |
1.86 | (0.41%) |
| 30 | 908 Devices Inc | MASS | 0.92% | 5.79 |
0.13 | (2.30%) |
| 31 | Caris Life Sciences Inc | CAI | 0.83% | 27.55 |
0.36 | (1.34%) |
| 32 | Veeva Systems Inc-Class A | VEEV | 0.73% | 219.07 |
3.61 | (1.67%) |
| 33 | Quantum-Si Inc | QSI | 0.69% | 1.30 |
0.09 | (7.92%) |
| 34 | Goldman Fs Trsy Oblig Inst 468 | 0.39% | 0.00 |
0.00 | (0.00%) | |
| 35 | Standard Biotools Inc | LAB | 0.37% | 1.60 |
0.04 | (2.90%) |
| ARKK | 80.20 |
2.50 | (3.22%) |
| ARKQ | 113.19 |
3.40 | (3.10%) |
| ARKW | 153.54 |
4.53 | (3.04%) |
| ARKG | 29.96 |
0.88 | (3.04%) |
| ARKF | 49.16 |
1.48 | (3.10%) |
| ARKX | 28.08 |
0.80 | (2.93%) |
| PRNT | 22.53 |
0.08 | (0.38%) |
| IZRL | 29.55 |
0.18 | (0.61%) |
The holdings for the ARK Genomic Revolution ETF are updated after each trading day. Exact holdings and weights are subject to change daily. There are currently 35 holdings in the fund.
Data as of 12/17/2025.